CHEK 1 (-7.41%)
IL0011336851• Medical Diagnostics & Research• Diagnostics & Research
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. CHEK

Check-Cap (CHEK) Competitor Comparison

We are evaluating the key criteria listed to compare Check-Cap (CHEK) against its competitors in the Diagnostics & Research industry.

Market Capitalization

0 / 58

Gross Profits

0 / 52

Total Revenue

0 / 57

EBITDA

0 / 56

Free Cashflow

0 / 56

Quick Ratio

0 / 57

Earnings per Share

0 / 56

Dividend yield

0 / 9

Total Cash

0 / 57

Performance 3 years

0 / 58

Performance 5 years

0 / 58

Performance 10 years

0 / 58

Linearity 3 years

0 / 58

Linearity 5 years

0 / 58

Linearity 10 years

0 / 58

Total Rank

0 / 58

Dividend Rank

0 / 58

Valuation Rank

0 / 58

Piotroski Rank

0 / 58

Muliplier Rank

0 / 58

Performance 3 years - CHEK ranking 0 / 58

These are the competitors of Check-Cap in the industry Diagnostics & Research ranked by performance 3 years
1. Meridian Bioscience VIVO
246.63
2. Lantheus Holdings LNTH
202.87
3. RadNet RDNT
116.12
4. Medpace Holdings MEDP
59.23
5. Heska HSKA
41.31
6. PerkinElmer PKI
21.19
7. Natera NTRA
15.79
8. Ortho Clinical Diagnostics Holdings OCDX
13.74
9. Quest Diagnostics DGX
13.32
10. Waters WAT
11.24
11. Laboratory Corp of America Holdings LH
1.91
12. Danaher DHR
-6.05
13. Thermo Fisher Scientific TMO
-11.22
14. IQVIA Holdings IQV
-11.8
15. Agilent Technologies A
-12.94
16. Mettler-Toledo MTD
-14.2
17. Syneos Health SYNH
-19.01
18. Qiagen QGEN
-19.34
19. Icon ICLR
-19.76
20. Olink Holding OLK
-22.2
21. Bioventus BVS
-28.32
22. Anixa Biosciences ANIX
-30.51
23. IDEXX Laboratories IDXX
-32.09
24. Sera Prognostics SERA
-38.05
25. Sotera Health SHC
-40.41
26. Charles River Laboratories CRL
-42.79
27. Myriad Genetics MYGN
-43.4
28. Exact Sciences EXAS
-48.15
29. CareDx CDNA
-49.97
30. DexCom DXCM
-56.1
31. National Research NRC
-59.23
32. NeoGenomics NEO
-61.37
33. Interpace Biosciences IDXG
-61.53
34. Illumina ILMN
-61.82
35. Neogen NEOG
-64.43
36. Enzo Biochem ENZ
-65.36
37. Twist Bioscience TWST
-66.77
38. Global Cord Blood CO
-67.25
39. MaxCyte MXCT
-70.19
40. Psychemedics PMD
-73.47
41. Guardant Health GH
-74.25
42. Fulgent Genetics FLGT
-74.98
43. Exagen XGN
-77.66
44. Personalis PSNL
-77.8
45. Biodesix BDSX
-81.54
46. MDxHealth MDXH
-83.08
47. bioAffinity Technologies BIAF
-83.69
48. Trinity Biotech TRIB
-83.74
49. Co-Diagnostics CODX
-86.15
50. Precipio PRPO
-86.91
51. Organovo Holdings ONVO
-89.19
52. Neuronetics STIM
-91.07
53. Pacific Biosciences of California PACB
-92.08
54. DarioHealth DRIO
-93.77
55. Inotiv NOTV
-94.55
56. SeqLL SQL
-95.69
57. Prenetics Global PRE
-96
58. Aspira Womens Health AWH
-98.83
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.